Discover cutting-edge studies on carcinogenesis, biomarkers, and targeted therapeutic approaches
Discover how the structural breakthrough of Folate Receptor Alpha (FRα) has revolutionized targeted cancer therapies, enabling precision treatments for ovarian, lung, and other carcinomas.